Showing results (481-490 of 909) with videos related to
Sort By:
Pageof 91
Circulation|December 7, 2005
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patientsScott D Solomon, Nagesh Anavekar, Hicham Skali, et al.Circulation|September 15, 2004
Effect of pravastatin on cardiovascular events in people with chronic kidney diseaseMarcello Tonelli, Chris Isles, Gary C Curhan, et al.European Journal of Heart Failure|January 30, 2009
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Nathaniel M Hawkins, Zhen Huang, Karen S Pieper, et al.Diabetes, Obesity & Metabolism|October 4, 2022
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist usePeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.Journal of Hypertension|October 5, 2019
Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trialLuca Monzo, João Pedro Ferreira, Paula Abreu, et al.Journal of the American College of Cardiology|July 13, 2010
Cardiovascular events during differing hypertension therapies in patients with diabetesMichael A Weber, George L Bakris, Kenneth Jamerson, et al.International Journal of Cardiology|January 13, 2009
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched studyO James Ekundayo, Chris Adamopoulos, Mustafa I Ahmed, et al.International Journal of Cardiology|June 9, 2009
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched studyMustafa I Ahmed, O James Ekundayo, Marjan Mujib, et al.Journal of the American College of Cardiology|May 20, 2021
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, George L Bakris, Bertram Pitt, et al.American Heart Journal|November 19, 2011
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programCono A Ariti, John G F Cleland, Stuart J Pocock, et al.Pageof 91